Evidence map›Paper›PMID 39567387›Full record

ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2024

Prevalence and clinical impact of radiographic sclerotic lines adjacent to cementless tibial stems in revision total knee arthroplasty: a long-term follow-up study.

Arieh Greenberg, Daniel Cohen, Seper Ekhtiari, Nada Read Abughaduma, Raja Hakim, Bardia Barimani, Jesse Wolfstadt, David Backstein

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arieh Greenberg *Granovsky Gluskin Orthopedic Division. Sinai Health System, Mount Sinai hospital, University of 476C-1, 600 University Avenue, Toronto, ON, M5G 1X5, Canada. arie.greenberg@yahoo.com.ORCID http://orcid.org/0000-0003-1642-7394
Daniel Cohen *Arthroplasty Unit. Sharee Zedek Medical Center, Affiliated to Hebrew University, Jerusalem, Israel.
Seper EkhtiariGranovsky Gluskin Orthopedic Division. Sinai Health System, Mount Sinai hospital, University of 476C-1, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.
Nada Read AbughadumaGranovsky Gluskin Orthopedic Division. Sinai Health System, Mount Sinai hospital, University of 476C-1, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.
Raja HakimGranovsky Gluskin Orthopedic Division. Sinai Health System, Mount Sinai hospital, University of 476C-1, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.
Bardia BarimaniDepartment of Orthopaedics, Arthroscopy and Joint Reconstruction University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
Jesse WolfstadtGranovsky Gluskin Orthopedic Division. Sinai Health System, Mount Sinai hospital, University of 476C-1, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.
David BacksteinGranovsky Gluskin Orthopedic Division. Sinai Health System, Mount Sinai hospital, University of 476C-1, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intramedullary stem extensions are typically added to the femoral and tibial components during revision total knee arthroplasty (TKA) to augment fixation of the components and improve survivorship. A commonly used option includes hybrid fixation with cement at the interface between the component and the host bone combined with cementless diaphyseal fitting stems. Radiographic sclerotic lines may appear with these constructs over time, and it is unclear if this finding has implications relative to implant survivorship. The purpose of this study was to quantify the prevalence of sclerotic lines at the bone-implant interface and assess the impact of progressive sclerotic lines on revision for aseptic loosening.

methodsA retrospective chart review of a consecutive series of patients who underwent revision TKA at a single tertiary care institution between January 2001 and December 2009 was performed. Data were collected regarding patient demographics, stem size, types of implants, and complications. Radiological reports and radiographs were evaluated for sclerotic lines, propagation, and their location around the tibial stem. Aseptic loosening rates were compared between patients with and without sclerotic lines.

resultsOne hundred and fifty-three patients with at least 15 years of follow-up were identified. The mean follow-up was 16.5 ± 4.12 years (range 15-23). Overall, 19 patients required re-revision surgery. Survivorship free of failure due to aseptic loosening was 94.8% (95% CI 76.4-98) at 15 years, with three patients requiring re-revision surgery for aseptic loosening. Twelve (7.8%) patients were found to have sclerotic lines surrounding the tibial stem, all under 2 mm in width. Two (1%) patients with sclerotic lines required re-revision surgery, one patient due to infection and one due to aseptic loosening. There was no significant difference in rates of aseptic loosening in patients with or without sclerotic lines.

conclusionRadiographic sclerotic lines around revision TKA stems-measuring less than 2mm wide, nonprogressive, and located at the lateral-distal aspect of the stem-were identified in fewer than 8% of cases and did not correlate with re-revision surgery.

Indexed as

Arthroplasty, Replacement, KneeKnee ProsthesisProsthesis FailureRadiographyReoperationTibiaAdultAgedAged, 80 and overBone-Implant InterfaceFemaleFollow-Up StudiesHumansMaleMiddle AgedPrevalenceRevisionSurvivorshipTotal knee arthroplasty

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.